Get started
Author

Silke H. Raffegerst

Observed names: Raffegerst Silke, Raffegerst, S., Raffegerst, Silke, S Raffegerst, S. Raffegerst, Silke Raffegerst, Silke H. Raffegerst
Institution: Medigene (Germany)
OpenAlex ID: A5113789458
Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
2012 · Daniel Nagel, Stefani Spranger, et al. · Cancer Cell · 233
PDF
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease
2001 · Zhen Su, Mario V. Peluso, et al. · European Journal of Immunology · 69
PDF
The CD6 Scavenger Receptor Is Differentially Expressed on a CD56dim Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion
2010 · Monika Braun, Bernadette Müller, et al. · Journal of Innate Immunity · 64
Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia
2000 · Xiao Chen, Sybille Regn, et al. · British Journal of Haematology · 58
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis
2000 · Xiao Chen, Anja Woiciechowsky, et al. · British Journal of Haematology · 55
Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant
2001 · S Regn, S Raffegerst, et al. · Bone Marrow Transplantation · 54
Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
2019 · Anja Mösch, Silke Raffegerst, et al. · Frontiers in Genetics · 42
PDF
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
2017 · Victor Jaravine, Anja Mösch, et al. · BMC Cancer · 27
PDF
Assessment of cancer and virus antigens for cross-reactivity in human tissues
2016 · Victor Jaravine, Silke Raffegerst, et al. · Bioinformatics · 20
Expitope: a web server for epitope expression
2015 · Kerstin Haase, Silke Raffegerst, et al. · Bioinformatics · 18
PDF
Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice
2009 · Silke H. Raffegerst, Gabriele Hoelzlwimmer, et al. · PLoS ONE · 11
PDF
Prevention of Tumor Formation by Latent Gammaherpesvirus Infection
2015 · S. Raffegerst, B. Steer, et al. · PLoS ONE · 7
PDF
DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment
2019 · Judith Eckl, Silke Raffegerst, et al. · Blood · 6
Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism
2002 · Zhen Su, Mario V. Peluso, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
2025 · Simone Thomas, Martin Wermke, et al. · Cancers · 1
PDF
A WT-1 and PRAME "Fast-DC" Immunotherapy As a Potential Post-Remission Strategy for AML
2020 · Yngvar Floisand, Iris Bigalke, et al. · Blood · 1
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
2013 · Carina Wehner, Christian Ellinger, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
1007P T-cells transgenic for a highly potent PRAME-specific TCR and a chimeric PD1-41BB co-stimulatory receptor represent a promising approach for the treatment of solid tumors
2021 · M. Bürdek, I. Fetzer, et al. · Annals of Oncology
The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases
2021 · Gary Waanders, Silke Raffegerst, et al. · Cell and Gene Therapy Insights
PRAME mRNA Expression in AML/MDS and HLA Genotype Analysis: Impact on Population Coverage and Design of TCR-Based Immunotherapies
2020 · Richard Addo, Kathrin Davari, et al. · Blood
Additional file 2 of Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
2017 · Jaravine, Victor, Mรถsch, Anja, et al. · Figshare
Additional file 3 of Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
2017 · Jaravine, Victor, Mรถsch, Anja, et al. · Figshare
Additional file 1 of Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
2017 · Jaravine, Victor, Mรถsch, Anja, et al. · Figshare
Additional file 4 of Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
2017 · Jaravine, Victor, Mรถsch, Anja, et al. · Figshare
Abstract A017: Method for molecular characterization of antigens, epitopes and T cell receptors for adoptive CD4 immunotherapy
2016 · Milosevic Slavoljub, Ellinger Christian, et al. · Cancer Immunology Research
Works count: 31
Citation count: 673
H-index: 11
I10-index: 11
Year
Topic
Type